Having trouble viewing this email? View it as a Web page.

Agenda for April Drug Utilization Review Board Meeting Now Available

The Texas Drug Utilization Review Board agenda for Friday, April 25, 2025, is now available.

Other News:

• Change in PDL Status for the Immunomodulators, Atopic Dermatitis and Ophthalmics, Anti-Inflammatories Drug Classes, Effective April 4, 2025
• Register Now for TMHP's Revalidation Extension and Retroactive Enrollment Period Webinars; Last Session Scheduled For May 1
• Awareness and Testing Resources for Hepatitis Awareness Month This May
• March 2025 Specialty Drug List Available

Pharmacy Education Reminders:

• Pharmacy Education Information and Opportunities
• Pharmacy Contact Information Must Be Current in PEMS